Both styles can result in too much daytime sleepiness. Research recommend that modafinil could be a promising drug that will reduce both equally daytime sleepiness and myotonia alone, without having important cardiac conduction outcomes, and that is important for patients with myotonic dystrophy who frequently have underlying cardiac problems.[270]